MRF Home  
 

To support medical RESEARCH for finding effective treatments and eventually a cure for melanoma.

MRF Research Background

To EDUCATE patients and physicians about the prevention, diagnosis and treatment of melanoma.

MRF Education

To act as an ADVOCATE for the melanoma community to raise the awareness of this disease and the need for a cure.

MRF Advocacy
       
Melanoma Info
It's A Fact Information Sheet

Melanoma Questions?: "Ask A Nurse"

Just Diagnosed

MRF Detection & Prevention

Research Program Background
Grant Announcements |  Submit Grant Application |  Grant Recipients

The purpose of  The Melanoma Research Foundation Research Grant Program is to support promising medical research that will further the goal of developing an effective treatment and possible cure of malignant melanoma, while encouraging scientists and clinicians to join in this mission.

The Foundation funds both junior and senior researchers.  In both grant programs, emphasis will be placed on projects that explore innovative approaches to understanding melanoma and its treatment. Both basic and clinical research projects will be considered.

Junior awards (Career Development Grant) will be given to investigators who are beginning a research career emphasizing melanoma-related projects and have not yet established strong federal funding. Up to $50,000 per year, for two years, may be provided.

Senior awards (Established Investigator Grant) will be given to established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. Up to $100,000 per year, for two years, may be provided.

Grant applications are submitted through the online grant application process. Eligibility requirements can be found under related documents.  We encourage all that meet the eligibility requirement to apply. 

If you have any questions, contact the Program Director via email -- research@melanoma.org.

Related Documents:
Career Development Research Fact Sheet 071207.pdf
Established Investigator Research Fact Sheet 071207.pdf
Fear of Recurrence Teleconference - September 17, 2008

Annual Melanoma Symposium - Irvine CA, Oct. 11

Educational Programs

MRF Supporter: John Dane III, member of the 2008 US Olympic Sailing Team

MRF Press Room

Low prevalence of cdkn2a arf mutations among early-onset cancers of breast, pancreas and malignant melanoma in poland.

Oncogenic brafv600e inhibits bim expression to promote melanoma cell survival

Phase ii trial of imatinib mesylate in patients with metastatic melanoma

Angiostatic activity of obtustatin as [alpha]1[beta]1 integrin inhibitor in experimental melanoma growth

More...

© Copyright 2007, The Melanoma Research Foundation (MRF) |   Disclaimer |  Contact us |   Home